The Week Ahead

Stay informed with our weekly buzz about what’s going on in Washington, DC.

louis-velazquez-XWW746i6WoM-unsplash-1-1920x1280

Week Ahead: The Beginning of the End

It’s the beginning of the end of summer recess. House members have made their way back to Washington for one week before they take another short break, as Senators still have another week before returning to town. Meanwhile, the administration is looking to keep its efforts on prescription drug pricing in the news, and the Medicare Payment Advisory Commission (MedPAC) will hold their September meeting. With that, let’s get into it. Welcome to the Week Ahead!

The Administration

New most-favored-nation (MFN) drug pricing deals are likely to be announced on August 31, this time with mid-sized biopharma companies. Reportedly, drugmakers will provide their products to Medicaid programs at MFN prices in exchange for tariff relief and exemptions from Medicare pilot discount programs. The Trump administration will certainly be looking to message these deals as a win in health care affordability to highlight ahead of the midterm elections. However, we expect Democratic members of Congress to combat that messaging by continuing to highlight the need for more details on which to judge the impact of these deals on prescription drug prices.

The Senate

The Senate is still enjoying their recess.

In contrast, Congressional advisory body MedPAC is kicking off their 2026-2027 analytic cycle with their first public meeting on September 3rd and 4th. The upcoming year will focus on numerous topics including recent trends in Medicare Part D spending, Medicare’s quality measurement and value-based payment programs, and Medicare Advantage utilization and satisfaction. As always, MedPAC will also be doing its annual work to consider the adequacy of Medicare’s fee-for-service (FFS) payments and updates.

The House

The House returns to consider a Senate-passed continuing resolution (CR) that would fund the government through December 11, 2026. House Republican leadership has indicated that they are hoping to pass the measure this week to avoid a government shutdown before the elections and will begin consideration as soon as September 1, according to the House Majority Leader’s weekly schedule. While the CR is mostly a continuation of existing federal funding, the Senate version did include a provision that would prevent new guidance from the Office of Management and Budget (OMB) on federal grantmaking from going to effect until December 11.

Health Care Hearing This Week

  • September 2: House Veterans’ Affairs Committee hearing on VA electronic health record modernization updates

There You Have It

The summer calm is nearly over but we hope the good memories will linger longer. What has been your favorite summer memory? Let us know. Make it a great week!

Week Ahead: Smelling the Jet Fuel??

If there is one thing senators on both sides can usually agree on, it’s the importance of August recess, especially during an election year. However, President Donald Trump’s demand that the Senate cancel the planned recess to pass the SAVE America Act and advance a budget reconciliation resolution has put pressure on Republicans to stay in town. Will the demands work? We’re on the edge of our seats. So, let’s get into it. Welcome to the Week Ahead!

The Administration

The Centers for Medicare and Medicaid Services (CMS) is hard at work on Medicare payment rules, reviewing stakeholder comments and getting rules finalized ahead of the next fiscal and calendar years. All of the final fiscal year rules for 2027, including the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals, the Inpatient Rehabilitation Facility Prospective Payment System, the Skilled Nursing Facility Prospective Payment System, the Inpatient Psychiatric Facility Prospective Payment System, and the Hospice Wage Index Proposed Payment System, have been pushed out the door but the comment periods for the 2027 calendar year payment rules, including the Physician Fee Schedule, Changes to the End-Stage Renal Disease Prospective Payment System, the Home Health Prospective Payment System, and the Hospital Outpatient Prospective Payment System, are still ongoing, so stakeholders are working on submitting their statements before the deadlines.

Meanwhile, the administration was handed a momentary win when a federal judge in Massachusetts denied a request for a preliminary injunction against parts  of the Medicaid work requirements interim final rule. The injunction request was made by 25 states and Washington, D.C., who are challenging the inclusion of a work requirement in the definition of medically frail, the use of a 12-month look-back period in assessing medical frailty claims, and the imposition of a work requirement on the short-term hardship exception. The judge ruled against the injunction request on the basis that the states did not show that it was necessary to prevent irreparable harm. However, the judge also noted that the denial was not a reflection or anticipation of what the court will ultimately decide in the lawsuit and the ruling said the court will set an expedited schedule to allow for full briefing ahead of the January 1, 2027, implementation deadline. Furthermore, the ruling noted that the injunction request was being denied without prejudice, meaning if the briefing continues to the implementation date of January 1, 2027, states could again ask the court to issue an injunction.

The Senate

Despite the pressure from President Trump and over a dozen senators to cancel recess, Senate Majority Leader John Thune (R-SD) has said he doesn’t see a reason to do so. Specifically, Leader Thune has said that the Senate has voted on the SAVE Act multiple times, and he doesn’t see how staying in town would change the result.  

As that drama plays out, Leader Thune has filed cloture on the legislative vehicle to extend government funding through December 4. The measure includes a provision to block President Trump’s rule to change the approval of grants (at least through December 11). There is also plenty of Committee-level work related to health care. The Senate Budget Committee is holding a hearing on Medicaid on August 4, which will be the first hearing that Sen. Ron Johnson (R-WI) has called since becoming Budget Chair, other than a previously scheduled business meeting to advance a nomination. Also on August 4, the Senate Finance Health Subcommittee is holding a hearing on biotechnology, and the Senate Judiciary Committee was planning on holding a hearing on how competition and transparency can lower drug costs, but it has been postponed.

The House

House members are enjoying their August recess.

There You Have It

Those of us here at Chamber Hill are also looking forward to the possibilities that August has to offer. What is your favorite summer activity? Let us know. Make it a great week!

pexels-ramaz-bluashvili-7016960-scaled-1-1920x1280

Week Ahead: The Final Stretch

Remember when you were a kid, and someone else’s school got out for summer before yours? That same deeply unfair feeling is settling over the Senate right about now. The House has packed its bags and headed home for summer break, while senators are still stuck at their desks watching their colleagues disappear into the sunshine while feeling the heat from the President on the SAVE Act. So, let’s get into it. Welcome to the Week Ahead!

The Administration

President Trump has announced his next set of tariffs on the pharmaceutical sector with a 100% tariff on imported generic drugs beginning in August 2028. John Murphy III, the President and CEO of the Association for Accessible Medicines (AAM)has said they need to see more specifics about the policy, but that the generics industry is committed to policies that stabilize the industry and patient access to affordable medications. On the Hill, Senate Finance Committee Ranking Member Ron Wyden (D-OR) introduced legislation to require congressional approval of tariffs before they take effect.

Attention is divided at the Centers for Disease Control and Prevention (CDC) as the agency deals with rising measles cases and the cyclosporiasis outbreak. Measles was declared eliminated in the US in 2000, but cases have been on the rise over the past few years. Over halfway through 2026, and the number of reported cases has surpassed 2025 levels, which was the most reported since 1991. Cyclosporiasis is also hitting new milestones as 9 states are now battling outbreaks. The Food and Drug Administration (FDA) is working with the CDC to investigate sources of the parasite and contain its spread. The simultaneous public health threats have fueled criticisms about public health funding levels and staffing cuts at the agencies. The lack of permanent leadership at the CDC and FDA is likely not helping the administration to contain the issues and will mean that any nominee will have a lot to clean up.

The Senate

The Senate must now pick up where the House left off and decide on the direction for Reconciliation 3.0. Senate Majority Leader John Thune (R-SD) has said he doesn’t have the votes to pass the House resolution and that his focus is on government funding. Thune has said that he plans to bring the House-passed continuing resolution (CR), which extends existing government funding through December 4, up for a vote before the Senate’s August recess. However, he has also said he would consider using Reconciliation to fund the government and avoid a shutdown if a CR cannot be passed. Notably, the CR does not include health care extenders, such as telehealth flexibilities and funding for Medicare-dependent and low-volume hospitals, that often accompany government funding bills because most of them are already extended until at least the end of the year.

Meanwhile, new Senate Budget Committee Chairman Ron Johnson (R-WI) shared that he has directed Budget Committee staff to begin drafting two Senate budget resolutions, with the goal to pass one of them before the August recess. The first would mirror the House resolution, and the second would be more expansive to ensure GOP funding priorities are met. Chairman Johnson also said he supports a fourth reconciliation package focused on addressing fraud. In discussing this, he cited Centers for Medicare and Medicaid Services actions against hospice providers in Los Angeles as an example of the sort of rampant fraud that needs to be addressed.

Also on our radar: Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bill Cassidy (R-LA) is looking to move on the Committee vote to advance the nomination of Dr. Erica Schwartz to be Director of the Centers for Disease Control and Prevention (CDC). This vote had to be delayed, despite Cassidy’s support, due to a family emergency affecting Sen. Lisa Murkowski (R-AK). Along with Dr. Schwartz’s nomination, the Committee also delayed a vote on the nomination of Sean Kaufman to serve as Assistant Secretary for Preparedness and Response (ASPR). During his nomination hearing, bipartisan concerns were raised about his views on vaccines. A HELP Committee spokesperson has shared that “there are ongoing conversations with the administration on the path forward for Mr. Kaufman’s nomination.” The Committee is scheduled to vote on his nomination, as well as bill from Chairman Cassidy on health privacy, during the July 30 executive session.

Other Health Care Hearings This Week

  • July 29: Senate Homeland Security Committee hearing with Dr. Anthony Fauci

The House

House Members are out of session until August 31.

There You Have It

What was your final week of school like when you were little?  Field days, yearbook signings, class parties?  Let us know your favorites!  Make it a great week.

Week Ahead: The Messi Calendar

Soccer fans had a Messi-filled weekend, and Congress is shaping up to have a messy week of its own. As congressional committees continue to work through legislation and nominations, House Republican leadership is looking to push a budget resolution, the NDAA, a stock trading ban, and a continuing resolution ahead of their August recess. But can they get it all done before the whistle blows? Let’s get into it. Welcome to the Week Ahead!

The Administration

The Centers for Medicare and Medicaid Services (CMS) is counting down to July 31, when the comment period for the interim final rule that implements the Medicaid work requirements put in place by the One Big Beautiful Bill Act closes. The rule’s provisions are legally in effect on that day (although states are not mandated to have their operational programs until January 1, 2027). 25 states, plus the District of Columbia, have challenged some of the agency’s interpretations of requirements under H.R. 1, the most notable being the narrow medical frailty exemption, arguing that the 2-part test goes beyond a plain language reading of the statute and puts vulnerable individuals with significant health care needs at risk of losing their coverage.

Meanwhile, the Trump administration is continuing its focus on the visa system, imposing more restrictions on the green card process. The State Department is considering adding a $100,000 bond to green card applications to “ensure immigrants are financially self-sufficient,” according to spokesperson Tommy Pigott. If the bond were to go into effect, it could be a significant barrier to nurses and medical technicians applying for a green card abroad as well as act as a deterrent for international medical graduates who apply outside the country. At the same time, the Department of Homeland Security has issued a final rule rescinding the 2022 regulation on public charge determinations that allowed authorities to consider only a green-card applicant’s use of cash benefits when determining whether the applicant would be a “public charge”. This change would mean that authorities could consider use of benefits, including Medicaid, in decisions about green card applications. Advocates have raised concerns that this would cause immigrants to avoid using programs like Medicaid, thus delaying care and ultimately forcing more individuals to rely on emergency room care.

The Senate

It’s a packed week for the Senate Committee on Health, Education, Labor, and Pensions (HELP). First up is the Committee’s executive session on a variety of health care bills on July 22. One of those bills is S. 4189, the INSULIN Act of 2026, which would cap the cost of insulin at $35 per month for individuals with private health insurance. This bipartisan bill is being co-led by Sen. Susan Collins (R-ME) and has eight other committee members as cosponsors. Also on the docket is S. 2355, the Patients Deserve Price Tags Act, which is being led by HELP Committee members Sens. Roger Marshall (R-KS) and John Hickenlooper (D-CO). While the House Energy and Commerce and Ways and Means Committees have passed a number of health price transparency bills, the Patients Deserve Price Tags Act stands apart mainly on employer access to claims data. Other bills being considered include legislation on country-of-origin prescription labeling, access to generic medications, and food safety.

On July 23, the Senate HELP Committee will be voting on the nominations of Dr. Erica Schwartz, to be Director of the Centers for Disease Control and Prevention (CDC), and Sean Kaufman, to be Assistant Secretary of Preparedness and Response (ASPR). During the nomination hearing on July 15, sparks flew as HELP Chairman Bill Cassidy (R-LA) pressed both nominees on their view of vaccines and whether they would be influenced by political pressures. Several senators on the committee, including Sens. Lisa Murkowski (R-AK), Andy Kim (D-NJ), Tim Kaine (D-VA), Tammy Baldwin (D-WI), and John Hickenlooper (D-CO), told reporters on July 16 they were undecided on how they will vote. This complicates the path forward as the nominees will need the support of all Republicans on the Committee if all Democratic members oppose their nominations.

Other Health Care Hearings This Week

  • July 22: Senate Indian Affairs Committee meeting to consider the nomination of Mark Cruz to be Indian Health Service Director

The House

House Republican leaders are hoping for a hat trick as they look to advance the resolution necessary for a third budget reconciliation package. The House Budget Committee has set up the shot by passing a resolution that calls for $95 billion in spending for the military, aid for farmers, and election measures. Although it also included a provision allowing for additional funding for the Health Care Fraud and Abuse Control Program, there were no instructions for the Committees with jurisdiction over Medicare and Medicaid. Despite the movement on the resolution, challenges still remain. These challenges include a thin majority in the House, limited floor time, and concerns from fiscal hawks who will want to offset the price tag, as well as from more moderate Republicans who may have issues with either funding tied to the Iran war or the election measures. And that’s just in the House. Some Senate Republicans, such as Sens. Rick Scott (R-FL) and Bill Cassidy (R-LA) have also voiced their concerns about the need for pay-fors.

At the same time, House Republicans have released the text for a Continuing Resolution (CR) that would fund the government at fiscal year 2026 levels through December 4, 2026. Speaker of the House Mike Johnson (R-LA-1) has plans to put the bill on the floor before they leave town. Although the CR does not include health care extenders (such as community health center funding and Medicare add-on payments) it does include funding for Indian Health Service staffing and facilities as well as  funding for the Supplemental Nutrition Program for Women, Infants, and Children (WIC), which is currently set to lapse on September 30, 2026. The House is also slated to consider thirteen health care bills. These include bills to reauthorize public health programs and to address needs for specific diseases and conditions. They also include a bill directing the Food and Drug Administration (FDA) to publish a final rule allowing non-animal testing in drug approvals, a bill clarifying Medicare payment rules for manual wheelchairs, and a bill allowing for the Secretary of Labor to suspend Federal Employees’ Compensation Act payments to medical providers convicted of fraud.

As the House deals with all this, the House Energy and Commerce Committee is holding a markup of various bills on July 20, including bills related to illicit drugs and health price transparency, that have passed out of the Health Subcommittee.

Other Health Care Hearings This Week

  • July 21: House Education and Workforce markup, including a bill to classify certain health care professionals serving in temporary roles as independent contractors
  • July 22: House Oversight Committee markup, including a bill to address concerns about certain pharmacy benefit manager (PBM) practices within the federal employee health insurance system

There You Have It

The World Cup has finally ended, with Spain emerging as the victors. Were you happy with the final game? Let us know. Make it a great week!

Crunch Time

There are only 8 more days left with both the House and the Senate in session before the August recess, and Congress has a lot on its plate. The top of the list includes fiscal year 2027 appropriations bills, Republican hopes for Reconciliation 3.0, and dealing with renewed conflict in Iran. Overshadowing it all is the unexpected death of Senate Budget Committee Chairman Lindsey Graham (R-SC). Let’s get into it. Welcome to the Week Ahead!

The Administration

The Department of Health and Human Services (HHS) postponed the U.S. Preventive Services Task Force’s meeting for the fourth time in the past year, citing an “unprecedented” volume of applications from prospective members. The delay follows a broader overhaul of the task force’s membership. In May, HHS removed chair John Wong and vice chair Esa Davis, and the agency has been soliciting nominations for a new slate of members. Given the pattern of repeated delays over the past year, it will be important to see if HHS names new task force members or sets a new meeting date in the coming weeks, and whether congressional Democrats and advocacy groups, who have previously pushed back on changes to the task force, respond to this latest postponement.

Meanwhile, the White House is once again focusing on the H-1B visa program with new a Department of Labor (DOL) investigation into visa fraud. Vice President Vance announced the new effort, following court challenges to the $100,000 H-1B fee imposed by the Trump administration in September 2025. The initiative will focus on checking underpayment of foreign workers, layoffs of qualified Americans, and labor trafficking. While much of the focus has been on the information technology industry, it will be important to pay attention to how the investigation impacts the health care workforce, which includes a significant number of H-1B visa holders.

The Senate

The passing of Sen. Graham has major implications for the Senate’s agenda, as he chaired the Senate Budget Committee, which would be responsible for drafting instructions for a third reconciliation bill. Sen. Ron Johnson (R-WI) is the most senior Republican on the Committee without an existing chairmanship, is next in line for the post and his office has said he is “prepared to serve.” Sen. Johnson is a staunch fiscal hawk who previously called for cuts during the debates over the first reconciliation package. This suggests he may demand cuts to offset the price tag of a third package. Sen. Graham’s passing also means that, until his temporary replacement is named and until Sen. Mitch McConnell (R-KY) returns, the Republican majority is down to 51 Senators.

The Senate Health, Education, Labor, and Pensions (HELP) Committee is looking to start filling in the gaps in federal health policy leadership with a nomination hearing on July 15. Up for review are Sean Kaufman to be Assistant Secretary for Preparedness and Response (ASPR) and Dr. Erica Schwartz to be Director of the Centers for Disease Control and Prevention (CDC). The nomination hearings indicate that HELP Committee Chairman Bill Cassidy (R-LA) is willing to work with the Trump administration to move forward with their picks despite losing his primary in May. Also, on his to-do list are nomination hearings for the US Surgeon General and the yet-to-be-announced Director for the Food and Drug Administration (FDA). And that’s assuming that Dr. Schwartz lasts longer than her predecessors’ 29 days!

We are also tracking a July 14 Senate Judiciary Committee hearing on how the debate over what products are eligible for patents impacts genetic medicine. Our conversations on the Hill indicate that the hearing will be focused on S. 1545, the Patent Eligibility Restoration Act of 2025 (PERA). If this bill were to eventually become law it would make it easier for diagnostic methods, genetic testing applications, and personalized-medicine inventions built around genetic material to be patented.

Other Health Care Hearings This Week

  • July 15: Senate Armed Services Personnel Subcommittee hearing on the Tricare pharmacy program
  • July 15: Senate Aging Committee hearing on foreign ownership and control in America’s drug supply chain

The House

House Republican leadership is returning to Washington after failing to advance appropriations bills before the July 4th recess. The House Rules Committee is scheduled to consider a rule on July 13 that would include the national security and Department of State appropriations legislation (along with a Veterans bill with a variety of health care provisions). However, it remains to be seen if House Republican leadership can overcome the efforts by some House Republicans to halt floor action unless progress is made on the SAVE America Act. At the same time, there continues to be interest in reconciliation 3.0 in the House, with some calling for provisions to enact health care priorities such as expanding access to health savings accounts and strengthening federal price transparency requirements. House Speaker Mike Johnson (R-LA-4) reportedly met with members of the House Budget Committee on July 12. Despite this movement, hurdles such as a thin Republican majority and dwindling days on the calendar make a third reconciliation package a tall order.

While the House as a whole deals with all these priorities and more, the House Energy and Commerce Health Subcommittee is set to examine America’s leadership in biomedical innovation and the FDA’s role in drug development on July 15. Based on our conversations on the Hill, we expect the hearing to include a focus on how the US can improve the drug research and approval process to be competitive with China, as well as drug user fee reauthorization.

Other Health Care Hearings This Week

  • July 14: House Education and Workforce Committee hearing on the impact of DEI on medical schools
  • July 15: House Select Committee on China hearing on the federal research security enterprise

There You Have It

Movies are a great way to take shelter from the summer heat, and July is setting up to have a lot of options between the new live-action Moana, The Odyssey, the next Spider-Man, and more. Is there one that you are looking forward to? Let us know. Make it a great week!